Inspite of having robust regulations; Pharma companies get away with sub standard BA/BE studies are This ultimately results in poor quality of generic drugs.. 2/2
#GenericDrugs When drug is off patent and can be manufactured as generic by pharma companies It is essential to conduct Bioavailability/ Bioequivalence (BA/BE) studies which will ensure similar ( >= 80%) efficacy of the generic compare Standard. 1/2
-
-
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.